SoftOx Solutions AS (6FV)

Overview

SoftOx Solutions AS is a pioneering enterprise positioned at the intersection of medtech and pharmaceutical domains, with its roots planted firmly in Norway. This entity, alongside its subsidiaries, embarks upon the mission of addressing a plethora of healthcare challenges through the development and distribution of innovative disinfection and infection treatment solutions. The foundation of the company was laid in 2012, with its headquarters established in Fornebu, Norway. It is geared towards the creation of products that not only combat a wide array of pathogens including bacteria, viruses, and fungi but also cater to the need for skin-friendly disinfectants. Moreover, SoftOx Solutions AS is actively involved in the research and development of groundbreaking treatments for both human and animal health, highlighting its commitment to advancing healthcare across species.

Products and Services

• SafeDes+: A specialized hand disinfectant designed with the needs of individuals with irritated, compromised, and eczematous skin in mind. This product stands out for its compatibility with sensitive skin, providing a solution that disinfects without exacerbating skin conditions.
• EffectDesH: A potent surface disinfectant acknowledged for its wide-ranging inactivation capabilities. EffectDesH is effective against bacteria, viruses, yeast, fungi, mycobacterium, and spores, ensuring a comprehensive disinfection solution for various environments.
• SoftOx Wound Irrigation Solutions: These solutions are meticulously formulated for both acute and chronic wounds to preempt and combat infections, including the challenging biofilms. Their application in wound care showcases SoftOx's dedication to facilitating healing and preventing infection with innovative approaches.
• SoftOx Anti-infectives: Targeted at treating and eradicating topical infections across wounded and mucosal tissues, these anti-infectives are formidable against biofilms, AMR microbes, viruses, and fungi. Their development is a testament to SoftOx's relentless pursuit of new solutions in the fight against resistant pathogens.
• Antiseptic Solutions for Pets and Livestock: Expanding its horizon beyond human healthcare, SoftOx is also developing antiseptic solutions tailored for pets and livestock. This initiative underscores the company's recognition of the interconnectedness of human and animal health.
• Inhalation Solution: Embarking on a venture into respiratory health, this novel inhaled drug is being developed for the early treatment and prevention of influenza-like illnesses. It represents a self-administered solution aiming to offer a preemptive shield against respiratory infections.